HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
4th Edition of
International Vaccines Congress
October 24 -26, 2024 | Baltimore, Maryland, USA
Event Book
Event program
Scientific Program
About
Magnus Group wishes to express our heartfelt gratitude for your valuable participation in the 4th International Vaccines Congress (IVC 2024), held in Baltimore, MD, USA, from October 24-26, 2024. Your engagement was a cornerstone of the event’s success, and the expertise you shared brought depth and richness to the discussions on key advancements in vaccine science. Your dedication to this critical field is truly inspiring, and we are grateful for the lasting impact you made on our community.
Scientific Committee Members
Regina Au
BioMarketing Insight, United States
Vincenzo Alfano
University of Napoli Parthenope, Italy
Sudhakar Bangera
AILEEN Clinical Research Services, IndiaSpeakers
David Craig Wright
D4 Labs, LLC, United States
Jocelyn jakubik
Meso Scale Diagnostics, United States
Carly Contri
American Academy of Pediatrics, United States
Chitra Upadhyay
Icahn School of Medicine at Mount Sinai, United States
Megha Mummalaneni
University of Nevada, Reno, School of Medicine, United States
Sudhakar Bangera
AILEEN Clinical Research Services, India
Madhu Khanna
University of Delhi, India
Dalinda Eusebio
CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal
Erez Shmueli
Tel-Aviv University, Israel
Lindsay Parish
BARDA, United StatesGallery
Vaccine Conference 2024 | Baltimore, MD, USA
Vaccine Conference 2023 | Boston, USA
Pharma Conference 2019 | Paris, France
Pharma Conference 2018 | Rome, Italy
Pharmaceutics Conference 2017 | Valencia, Spain
Reviews
Pharma Conference 2018 | Rome, Italy
Pharma Conference 2017 | Valencia, Spain
Magnus Group Conferences Reveiws
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Neutralizing antibodies response to SARS-COV-2 XBB1.5 mRNA vaccine in nephrology patients on dialysis against different viral variants
Agostino Riva, University of Milan, Italy
Title : The influence of physical factors on recombinant human serum albumin
Patrycja Dolibog, Medical University of Silesia in Katowice, Poland
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : Current investments and future directions of biomedical advanced research and development authority’s CBRN vaccines portfolio
Lindsay Parish, BARDA, United States